CardioKine is a specialty pharmaceutical company developing innovative compounds for the treatment and prevention of heart failure and related cardiovascular indications.

Heart failure is one of the world’s fastest growing diseases, impacting all segments of society. It occurs when the heart becomes too weak to pump blood, leading to accumulation of fluids, shortness of breath and premature death.

By developing and bringing to market a new generation of therapies, treatments and preventative measures, CardioKine is positioning itself as a leader in the fight against this debilitating condition.